Bio-responsive delivery of tissue plasminogen activator for localized thrombolysis
Authors:
- 1 March 2014
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 177, 42-50
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Serum albumin-protamine conjugate for biocompatible platform for targeted delivery of therapeutic macromoleculesJournal of Biomedical Materials Research Part A, 2013
- Design of reversibly core cross-linked micelles sensitive to reductive environmentJournal of Controlled Release, 2011
- Enzyme-Responsive Intracellular Controlled Release Using Nanometric Silica Mesoporous Supports Capped with “Saccharides”ACS Nano, 2010
- Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formationBlood, 2010
- Ultrasound-enhanced delivery of targeted echogenic liposomes in a novel ex vivo mouse aorta modelJournal of Controlled Release, 2010
- Thrombin generation and fibrin clot structureBlood Reviews, 2007
- Construction and characterization of a t-PA mutant for use in ATTEMPTS: A drug delivery system for achieving targeted thrombolysisJournal of Controlled Release, 2005
- RGD-modified liposomes targeted to activated platelets as a potential vascular drug delivery systemThrombosis and Haemostasis, 2005
- Comparison of TNK With Wild-Type Tissue Plasminogen Activator in a Rabbit Embolic Stroke ModelStroke, 2001
- Chemical modification of buried lysine residues of bovine serum albumin and its influence on protein conformation and bilirubin bindingBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1992